Cytokinetics (CYTK) Tops Q4 EPS by 4c, Revenues Beat; Offers FY19 Revenue Mid-Point Guidance Above Consensus
Go back to Cytokinetics (CYTK) Tops Q4 EPS by 4c, Revenues Beat; Offers FY19 Revenue Mid-Point Guidance Above Consensus| CYTOKINETICS (NASDAQ: CYTK) | Delayed: 75.87 +1.74 (2.35%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $74.13 | 52 Week High | $13.18 | |||
| Open | $73.90 | 52 Week Low | $6.00 | |||
| Day High | $75.92 | P/E | N/A | |||
| Day Low | $73.46 | EPS | $-1.24 | |||
| Volume | 1,492,023 | |||||

